Cartesian Therapeutics (RNAC) Other Working Capital Changes (2017 - 2024)
Cartesian Therapeutics (RNAC) posted quarterly Other Working Capital Changes of -$412000.0 for Q2 2024, up 37.0% year-over-year from -$300723.2 in Q3 2023, and up 92.42% quarter-over-quarter from -$5.4 million in Q1 2024.
Cartesian Therapeutics (RNAC) Other Working Capital Changes (2017 - 2024) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Other Working Capital Changes for 8 consecutive years, with -$412000.0 the latest figure, recorded in Q2 2024.
- In Q2 2024, Other Working Capital Changes rose 37.0% year-over-year to -$412000.0; the TTM figure through Mar 2025 stood at -$412000.0 (up 95.59% YoY), while the FY2024 annual figure was -$5.8 million, down 211.28% from the prior year.
- Other Working Capital Changes grew to -$412000.0 in Q2 2024 per RNAC's latest filing, from -$5.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.8 million in Q1 2025 and bottomed at -$2.8 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged $152411.8 across 5 years, with a median of -$70000.0 in 2022.
- On a YoY basis, Other Working Capital Changes climbed as much as 4875700.0% in 2020 and fell as far as 1542.86% in 2020.
- Cartesian Therapeutics' Other Working Capital Changes stood at -$5.0 million in 2020, then tumbled by 238.06% to -$17.1 million in 2021, then surged by 49.26% to -$8.7 million in 2022, then surged by 73.77% to -$2.3 million in 2023, then soared by 81.87% to -$412000.0 in 2024.
- Business Quant data shows RNAC's Other Working Capital Changes at -$412000.0 in Q2 2024, -$5.4 million in Q1 2024, and -$2.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -412,000.00 |
| Jun 30, 2024 | -412,000.00 |
| Jun 30, 2024 | -412,000.00 |
| Mar 31, 2024 | -5.44 Mn |
| Mar 31, 2024 | -5.44 Mn |
| Mar 31, 2024 | -5.44 Mn |
| Dec 31, 2023 | -2.27 Mn |
| Dec 31, 2023 | -2.27 Mn |
| Dec 31, 2023 | -2.27 Mn |
| Sep 30, 2023 | -976,000.00 |
| Sep 30, 2023 | -976,000.00 |
| Sep 30, 2023 | -976,000.00 |
| Jun 30, 2023 | -654,000.00 |
| Jun 30, 2023 | -654,000.00 |
| Jun 30, 2023 | -654,000.00 |
| Mar 31, 2023 | 9.16 Mn |
| Mar 31, 2023 | 9.16 Mn |
| Mar 31, 2023 | 9.16 Mn |
| Dec 31, 2022 | -8.66 Mn |
| Dec 31, 2022 | -8.66 Mn |